Read + Share
Amedeo Smart
Independent Medical Education
Ou SI, Janne PA, Leal TA, Rybkin II, et al. First-in-Human Phase I/IB Dose-Finding Study of Adagrasib (MRTX849) in Patients With Advanced KRAS(G12C) Solid Tumors (KRYSTAL-1). J Clin Oncol 2022;40:2530-2538.PMID: 35167329
Email
LinkedIn
Facebook
Twitter
Privacy Policy